VEGFA and diabetes mellitus: As an illustration of dosage sensitivity of the VEGF/VEGFR-2 system, whereas pharmacological VEGF inhibition attenuates albuminuria in experimental diabetes [6–9], the opposite effect has been described following genetic VEGF obliteration [12].